Suzuken Co. Reports FY2025 Financial Results with Increased Profit and Dividends

An update from Suzuken Co ( (JP:9987) ) is now available.

Suzuken Co., Ltd. reported its consolidated financial results for the fiscal year ending March 31, 2025, showing a slight increase in net sales by 0.6% to ¥2,399,952 million. Despite a challenging market environment, the company achieved a significant 18.9% rise in profit attributable to owners of the parent, amounting to ¥34,496 million. The company announced an increase in annual dividends from ¥80.00 to ¥100.00 per share, reflecting its commitment to returning value to shareholders. The financial forecast for the next fiscal year indicates a modest growth in net sales by 2.8%, though a decline in operating and ordinary profits is expected.

The most recent analyst rating on (JP:9987) stock is a Hold with a Yen5730.00 price target. To see the full list of analyst forecasts on Suzuken Co stock, see the JP:9987 Stock Forecast page.

More about Suzuken Co

Suzuken Co., Ltd. is a company listed on the Tokyo, Nagoya, and Sapporo Stock Exchanges. It operates in the pharmaceutical distribution industry, providing a range of healthcare-related products and services.

Average Trading Volume: 245,345

Technical Sentiment Signal: Strong Buy

Current Market Cap: Yen299.3B

Find detailed analytics on 9987 stock on TipRanks’ Stock Analysis page.